We offer a broad portfolio of Actives Pharmaceutical Ingredients and Finished Products:
APIs
- Small molecule APIs
- Peptides
Finished Products
- Biosimilars
- Solid Orals
- Injectables
- Ophthalmics
Highlights
- A portfolio of 54 small molecule API's
- 3 Peptides commercially available and 3 under development.
- 10 Biosimilars under various stages of development.
- 6 Injectables under development.
- 7 Ophthalmics under development
- A Portfolio of 30 Solid Orals for US Market
- A Portfolio of 29 Solid Orals for EU Market
These are manufactured at our cGMP compliant plants in India which are ISO 14001 and OHSAS 18001 certified.
Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.
|
